In the same line, many of the drugs that were given simultaneously with the GLP1RAs were administered in a single dose, again raising the question of whether the results can be inferred to the context of chronic use with multiple doses
Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial
In the SURPASS-2 trial published in the New England Journal of Medicine, tirzepatide at 15 mg produced an average weight loss of 11.2 kg compared to 5.7 kg with semaglutide 1 mg over 40 weeks
You shouldnt take acid-reducing medications for long since it can affect how your body absorbs B12
The former could be caused by elevated norepinephrine, as catechol-O-methyltransferase (COMT) degrades monoamines (Hall et al., 2019)
Be mindful of how you sitfeet flat, shoulders back, hips supported